The CDC has officially ended its emergency response to H5N1 bird flu due to a significant drop in cases and no human infections reported since February 2025. Experts weigh in on future risks.
In a surprising move, the HHS has terminated a $590 million contract with Moderna for H5 avian influenza vaccine development, raising alarms among health experts amidst rising H5N1 threats.
This flu season has seen the highest number of pediatric deaths since the swine flu pandemic, with alarming statistics emerging from the CDC. Experts warn of a potential undercount and emphasize the need for increased vaccination rates among children.
The U.S. Department of Health and Human Services is on a bold mission to develop a universal flu vaccine within four years, a project that could revolutionize how we combat influenza and prepare for future pandemics. Funded by $500 million, this initiative aims for FDA approval by 2029, with clinical trials starting soon. Experts weigh in on the challenges and potential of this ambitious project.
Experts warn that the H5N1 bird flu virus, which has already infected humans and mammals, continues to evolve. As outbreaks persist, the potential for a pandemic looms closer than ever. Are we prepared for what's next?
With a severe bird flu outbreak ravaging poultry and dairy farms, concerns rise as President Trump's administration sidelines the Office of Pandemic Preparedness and Response, leaving only one staffer to coordinate efforts.
Experts are sounding the alarm about the potential for an H5N1 bird flu pandemic, urging immediate action to prevent severe illness and ensure equitable vaccine access worldwide. With recent cases and mutations, the time to act is now!
A Washington State company has issued a recall of its raw cat food due to potential bird flu contamination. At least one pet has died after consuming the product, prompting urgent safety measures.
In an unprecedented move, U.S. Senators express deep concerns over the FDA's cancellation of a critical VRBPAC meeting, risking vaccine availability during the worst flu season in 15 years. The senators demand accountability and clarity from nominee Dr. Marty Makary.
The recent cancellation of a key FDA meeting on flu vaccine strains has raised alarms among health experts, who fear it could impact vaccine quality and availability. With flu season approaching, is the U.S. prepared to protect its citizens?
